Dermatomyositis with splenic and renal infarctions during corticosteroid therapy

Internal Medicine

Volumn 39, Issue 6, 2000, Pages 512-516

  Matsuda, Yuko ^a   Harigai, Masayoshi ^a   Nakajima, Hiroshi ^a   Terajima, Hisae ^a   Yamada, Tohru ^a   Fukasawa, Chikako ^a   Takeuchi, Megumi ^a   Hara, Masako ^a   Kamatani, Naoyuki ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Cyclophosphamide; Hypercoagulability; Vasculitis

Indexed keywords

ALTEPLASE; CYCLOPHOSPHAMIDE; HEPARIN; PREDNISOLONE; WARFARIN;

ADULT; ANGIOGRAPHY; ARTICLE; CASE REPORT; CORTICOSTEROID THERAPY; DERMATOMYOSITIS; FEMALE; HUMAN; KIDNEY INFARCTION; SPLEEN INFARCTION; TREATMENT OUTCOME;

EID: 0033933627     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.39.512     Document Type: Article

References (14)

1. See Y, Martin K, Rooney M, Woo P. Severe juvenile dermatomyositis complicated by pancreatitis. Br J Rheumatol 36: 912-916, 1997.
2. Jimenez C, Rowe PC, Keene D. Cardiac and central nervous system vasculitis in a child with dermatomyositis. J Child Neurol 9: 297-300, 1994.
3. Argiris A. Splenic and renal infarctions complicating atrial fibrillation. Mt Sinai J Med 64: 342-349, 1997.
4. Eshraghi N, Farahmand M, Maerz LL, Campbell SM, Deveney CW, Sheppard BC. Adult-onset dermatomyositis with severe gastrointestinal manifestations: Case report and review of the literature. Surgery 123: 356-358, 1998.
5. Krnic-Barrie S, O'Connor CR, Looney SW, Pierangeli SS, Harris EN. A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis. Arch Intern Med 157: 2101-2108, 1997.
6. Espinoza LR. Antiphospholipid antibody syndrome: treatment. Lupus 5: 456-457, 1996.
7. Hernandez D, Dominguez ML, Diaz F, et al. Renal infarction in a severely hypertensive patient with lupus erythematosus and antiphospholipid antibodies. Nephron 72: 298-301, 1996.
8. Poux JM, Boudet R, Lacroix P, et al. Renal infarction and thrombosis of the infrarenal aorta in a 35-year-old man with primary antiphospholipid syndrome. Am J Kidney Dis 27: 721-725, 1996.
9. Sonpal GM, Sharma A, Miller A. Primary antiphospholipid antibody syndrome, renal infarction and hypertension. J Rheumatol 20: 1221-1223, 1993.
10. Petri M. Thrombosis and systemic lupus erythematosus: the Hopkins Lupus Cohort perspective. Scand J Rheumatol 25: 191-193, 1996 (editorial).
11. Maxwell SRJ, Moots RJ, Kendall MJ. Corticosteroids: do they damage the cardiovascular system? Postgrad Med J 70: 863-870, 1994.
12. Wadman B, Werner I. Thromboembolic complications during corticosteroid treatment of temporal arteritis. Lancet 1 (7756): 907, 1972.
13. Richmond R, McMillan TW, Luqmani RA. Optimisation of cyclophosphamide therapy in systemic vasculitis. Clin Pharmacokinet 34: 79-90, 1998.
14. Tateishi M, Taniguchi A, Moriguchi M, Hara M, Kashiwazaki S. Cyclophosphamide pulse therapy for refractory rheumatic diseases. Nihon Rinsho Men-eki Gakkai Kaishi (Jpn J Clin Immunol ) 20:152-158, 1997 (in Japanese, Abstract in English).